Diagnostic Value of Thrombus Size on T2<sup>*</sup>-weighted Gradient Echo Imaging in Acute Middle Cerebral Artery Occlusion

Yong-Hwan Cho; Hyun-Seok Park; Jae-Hyung Choi; Jae-Kwan Cha; Jae-Taeck Huh

doi:10.7461/jcen.2014.16.2.85

J Cerebrovasc Endovasc Neurosurg > Volume 16(2); 2014 > Article

Cho, Park, Choi, Cha, and Huh: Diagnostic Value of Thrombus Size on T2*-weighted Gradient Echo Imaging in Acute Middle Cerebral Artery Occlusion

Original Article

Journal of Cerebrovascular and Endovascular Neurosurgery 2014;16(2):85-92.

Published online: June 30, 2014

DOI: https://doi.org/10.7461/jcen.2014.16.2.85

Diagnostic Value of Thrombus Size on T2^*-weighted Gradient Echo Imaging in Acute Middle Cerebral Artery Occlusion

Yong-Hwan Cho¹, Hyun-Seok Park¹, Jae-Hyung Choi¹, Jae-Kwan Cha², Jae-Taeck Huh¹

¹Department of Neurosurgery, Busan-Ulsan Regional Cardiocerebrovascular Center, Medical Science Research Center, College of Medicine, Dong-A University, Busan, Korea.

²Department of Neurology, Busan-Ulsan Regional Cardiocerebrovascular Center, Medical Science Research Center, College of Medicine, Dong-A University, Busan, Korea.

Correspondence to Jae-Taeck Huh. Department of Neurosurgery, Busan-Ulsan Regional Cardiocerebrovascular Center, Medical Science Research Center, College of Medicine, Dong-A University, Dongdaeshin-dong 3-ga, Seo-gu, Busan 602-715, Korea.
Tel: 82-51-240-5241, Fax: 82-51-242-6714, jthuh@dau.ac.kr

Received January 06, 2014 Revised March 25, 2014 Accepted May 21, 2014

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Objective

The T2^*-weighted gradient echo image susceptibility vessel sign (GRE SVS) is a well-known indicator of intraluminal thrombi in acute cerebral infarction. The purpose of this study was to evaluate the relationships between thrombus size on GRE SVS and recanalization after intravenous administration of tissue plasminogen activator (IV-tPA).

Materials and Methods

Fifty five patients with GRE SVSs on the M1 were enrolled. Examination of magnetic resonance image (MRI), including diffusion weighted imaging and MR angiography, was performed within 20 minutes of admission. Thrombus size on GRE was calculated using the Picture Archiving and Communication System upon initial MRI. Recanalization was assessed with follow-up MRI or transfemoral cerebral angiography within 24 hours of treatment.

Results

The patient group consisted of 37 males and 18 females with an average age of 63.74 ± 10.28 years (range: 43 - 77 years). The median NIHSS score was 13. Fifteen of these patients achieved recanalization (27.3%). The average thrombus cross-sectional area in the recanalization group was 38.54 ± 20.27 mm², and the corresponding size of the non-recanalization group was 53.38 ± 24.77 mm² (p = 0.043). In the receiver operator characteristic curve for thrombus cross-sectional area in relation to recanalization, the cut-off point was 47.28 mm². The sensitivity at this cut-off point was 73.3%, the specificity was 60%, and the area under the curve was 0.687.

Conclusion

Thrombus size on GRE is a simple diagnostic tool that can be easily measured, and thrombus size on GRE SVS was found to be associated with recanalization after IV-tPA.

Keywords: Cerebral arterial occlusion, Tissue plasminogen activator, Thrombus, T2^*, Susceptibility vessel sign

INTRODUCTION

Acute ischemic stroke is an event of the highest urgency. Persistent major cerebral arterial occlusion is associated with high mortality and poor neurologic outcome.6)20) Recanalization using intravenous administration of tissue plasminogen activator (IV-tPA) or intra-arterial chemical thrombolysis (IAT) has been shown to improve patient outcome.2)7)22) Endovascular mechanical thrombectomy (MT) has recently been shown to induce high-grade, rapid recanalization, resulting in favorable clinical outcomes.8)9)16)

To date, several studies have reported on the usefulness of assessment of thrombus burden using computed tomography (CT) angiography in prediction of clinical and radiologic outcomes.1)11)21) In addition, a small number of studies using magnetic resonance image (MRI) for estimation of treatment outcomes and thrombus burdens have been reported. Cho et al. suggested that the magnetic susceptibility effect of deoxyhemoglobin in intraluminal clots, which appears as a hypointense signal on T2^*-weighted gradient echo (GRE) images, might predict cardioembolic stroke and subsequent recanalization. These authors termed this radiologic finding the "GRE susceptibility vessel sign (GRE SVS)".4) However, Schellinger et al. reported that the GRE SVS can aid in diagnosis of ischemic disease but does not predict recanalization.19) Previous studies have focused solely on the presence of GRE SVS and recanalization after thrombolytic treatment. Correlations between thrombus size according to GRE SVS and recanalization after IV-tPA have not been thoroughly investigated.

The current study was conducted for analysis of the relationships between thrombus size of GRE SVS and recanalization after thrombolytic therapy using IV-tPA.

MATERIALS AND METHODS

Patient selection

Between October 2005 and August 2013, 408 patients with acute ischemic stroke including the middle cerebral artery territory were treated with thrombolytic therapy using IV-tPA (IV-tPA was performed within 3 hours of symptom onset). Clot location can affect clot dissolution, and internal carotid artery (ICA) terminus occlusions are the least likely to be recanalized with IV-tPA.12)18) Thus, in order to minimize the influence of clot location, ICA terminus occlusions were excluded, and the author limited the inclusion criteria such that only M1 occlusion patients were included in this study. The author performed a retrospective analysis of the clinical (underlying disease and National Institutes of Health Stroke Scale (NIHSS)) and imaging (initial and follow up MRI, or cerebral angiography) data of 55 patients who showed GRE SVS on their initial MRI.

Treatment algorithm and assessment

On admission, neurologic assessments based on the NIHSS were performed by a stroke neurologist. All patients underwent a multimodal MRI prior to thrombolytic therapy, within 20 minutes of admission. The multimodal MRI protocol included diffusion-weighted imaging (DWI), GRE, a fluid attenuated inversion recovery sequence, 3D time-of-flight MR angiography (MRA), and perfusion-weighted imaging (PWI). Follow up MRIs were performed within 24 hours of thrombolytic therapy. Subsequent transfemoral cerebral angiography (TFCA) was considered for patients who failed to exhibit neurologic improvement within 1 hour of IV-tPA. IV-tPA (0.9 mg/kg) was infused over 60 minutes, and 10% of the total dose was administered in an initial bolus over 1 minute.

Image analysis

GRE SVS was defined by hypointense signals in the cerebral artery in axial section T2^*-weighted gradient echo images of the territory that corresponded to high signal on the DWIs. MRI examinations were performed on a 1.5 T unit. The common MRI parameters for DWI and GRE were an equivalent slice thickness of 5 mm, an interslice gap of 2 mm, 20 axial slices, and field-of-view of 220 × 220. DWI parameters included a repetition time (TR) of 3000 ms, an echo time (TE) of 73.5 ms, and a matrix number of 160 × 160. GRE parameters were TR of 550 ms, a TE of 20 ms, a matrix number of 256 × 192, and a flip angle of 20°. MRA parameters included a flip angle of 20°, a matrix number of 256 × 192, a field-of-view of 210 × 210, TR of 25 ms, and TE of 6.3 ms.

For estimation of thrombus size, which can represent the actual thrombus volume, the cross-sectional areas of the GRE SVSs on the initial MRI were calculated. The approximate volume of the mass on MRI can be expressed as summation of the products of cross-sectional areas and slice thickness. The average diameter of M1 is 3.35 mm.14) Therefore, GRE SVSs on M1 usually appeared in a slice, and we calculated thrombus cross-sectional area as a representative value of thrombus volume. Radiographic estimations of the cross-sectional areas of the thrombi based on the GRE SVSs were performed using the Picture Archiving and Communication System (PACS; Maroview version 5.4, MAROTECH Inc., Seoul, Korea) and a region of interest (ROI) calculator (Fig. 1). When the GRE SVSs appeared in two slices due to curvature of MCA, the areas were summed.

Recanalization was defined as the reappearance of the distal part of the occluded vessel on the follow-up MRI. In following TFCA, recanalization was graded according to Thrombolysis in Cerebral Infarction (TICI) scores (Grade 0: no perfusion; Grade 1: penetration with minimal perfusion; Grade 2a: partial filling (< 2/3) of the vascular territory; Grade 2b: complete filling of the vascular territory that occurs more slowly than normal; and Grade 3: complete perfusion).10) TICI grades of 2b and 3 were considered to indicate successful recanalization.

Statistical analyses

Chi-square tests were used to examine factors that may have affected recanalization. Independent samples t-tests were performed for comparison of average values. Median tests were used for comparison of NIHSS scores. For estimation of the diagnostic value of thrombus size in terms of recanalization after IV-tPA, a receiver operator characteristic (ROC) curve test was performed, and the cut-off value that maximized the sensitivity and specificity was calculated. Binary logistic regression analysis was performed using SPSS 12.0 (SPSS INC., Chicago, IL, USA) for estimation of the independent contributions of the variables. Statistical analyses were performed using SAS version 9.2 (SAS Institute, Cary, NC, USA), with the exception of the logistic regression, which was performed using SPSS 12.0 for Windows. All p values below 0.05 were considered statistically significant.

RESULTS

Our patient pool consisted of 55 patients (37 males and 18 females) with an average age of 63.74 ± 10.28 years (range: 43-77 years). The median NIHSS score was 13. Fifteen patients (27.3%) achieved recanalization after IV-tPA, and the average thrombus size of the recanalization group was 38.54 ± 20.27 (12.62-91.40) mm². The average thrombus size of the non-recanalization group was 53.38 ± 24.77 (9.97-95.64) mm² (p = 0.043). In addition, patients with small thrombi (≤ 47.43 mm²; i.e., the median value of this data) were more likely to achieve recanalization than patients with large thrombi (> 47.43 mm²) (p = 0.008). The times between symptom onset and IV-tPA were 155.93 ± 54.62 and 117.35 ± 38.16 minutes for the recanalization group and the non-recanalization group, respectively (p = 0.005). Patients with longer IV-tPA onset times (> 120 mins) were more likely to achieve recanalization (p = 0.013) (Table 1). In addition, among patients with small thrombi (≤ 47.43 mm²), the IV-tPA onset time of the recanalization group was longer than that of the non-recanalization group (Table 2). Results of multivariate analysis showed an association of thrombus size (p = 0.017) and IV-tPA onset time (p = 0.043) with recanalization and thrombi sizes smaller than 47.43 mm² and IV-tPA onset times over 120 minutes were associated with increased odds ratios (Table 3). Fig. 2 illustrates the ROC curve for thrombus cross-sectional area in relation to recanalization. The thrombus size of the cut-off point was 47.28 mm², which was similar to the median thrombus size. The sensitivity at this cut-off point was 73.3%, the specificity was 60%, and the area under the curve was 0.687. This cut-off point may be relatively valuable in predicting recanalization after IV-tPA. No differences in initial NIHSS scores, diabetes mellitus (DM), hypertension (HTN), or smoking were observed between the recanalization and non-recanalization groups.

DISCUSSION

After intracranial hemorrhage, oxyhemoglobin in the blood is transformed into deoxyhemoglobin, followed by methemoglobin, and finally hemosiderin. Deoxyhemoglobin, methemoglobin, and hemosiderin have paramagnetic effects that cause hypointense signals on MRI, particularly on GRE.12)15) Intraluminal clots proceed through a sequential degradation similar to that observed after intracranial hemorrhage. Thus, thrombi in occluded vessels appear as hypointense signals on GRE. GRE SVSs might predict cardioembolic stroke and may be associated with subsequent recanalization due to the high binding affinity of tPA for fibrin, which is enriched in the red thrombi that compose cardiac emboli.4) Some previous studies have shown that thrombus burden on CT can be a useful diagnostic tool for prediction of clinical and radiological outcome.1)11)21) There are some reports on SVS and thrombus burden on CT. Sakamoto et al. reported that SVS and hyperdense MCA sign may represent the same thrombus.17) Legrand et al., who adapted the CT angiography-based Clot Burden Score (CBS) to T2^*-MRI, reported an association of high clot burden with lower 24-hour recanalization rate. The CBS, a scoring system for defining the extent of thrombus, is a semi-quantitative score.13) In the current study, the author attempts to quantify the thrombus burden.

The current study was conducted for examination of thrombus size according to GRE SVS and recanalization after IV-tPA. In this study of thrombus size and recanalization after IV-tPA, thrombus size on GRE SVS was found to shown an association with recanalization (p = 0.017). Patients with acute M1 occlusions and small thrombi size were more likely to achieve recanalization after IV-tPA. Thus, neurointerventions that immediately follow IV-tPA are recommended for acute ischemic stroke patients with large GRE SVS.

A previous study reported a higher recanalization rate and more favorable functional outcomes for patients who underwent IV-tPA prior to MT than for those who underwent MT without IV-tPA.5) Use of IV-tPA may improve the recanalization rate of MT even if immediate recanalization fails. Another recent study reported that MT is effective in acute ischemic stroke without GRE SVS.3) Thus, if a patient has a large thrombus based on GRE SVS or has MCA stenosis and thrombotic occlusion without GRE SVS, immediately following IV-tPA with MT may be a useful strategy for treatment of M1 total occlusion.

Among patients who underwent IV-tPA and had small thrombi (≤ 47.43 mm²), the treatment onset time was longer among patients who achieve recanalization compared with those who did not achieve recanalization (Table 2). Thus, the recanalizing group experienced longer IV-tPA onset times than the non-recanalizing group (Table 1). These finding can be interpreted according to thrombus size and severity of symptoms. We speculated that acute ischemic stroke patients with small thrombi might have milder symptoms than patients with large thrombi and thus could take longer time to visit the hospital. However, the location of occlusion and the existence of collateral flow might influence the severity of the initial symptoms; therefore, a larger scale study with more variables may be needed in order to reach statistical significance.

Based on results shown in Tables 2 and 3, it is likely that thrombus size has a greater influence on recanalization than time to IV-tPA treatment dose.

The current study had several limitations. First, the spatial extents of GRE SVSs are not well defined, and this lack of definition has been referred to as a "blooming effect".23) Due to this effect, the thrombus areas on GRE appear larger than the actual thrombi, and GRE SVS might not be indicative of the true thrombus burden. However, in this study, all patients visited the hospital within 3 hours of stroke; thus, the intraluminal clots were examined after limited amounts of time had passed, and these clots had undergone similar levels of deoxygenation. Thus, these intraluminal clots had similar paramagnetic effects, and the thrombus sizes of each case were somewhat accurate indicators of clot burden. In addition, correlations were found between GRE SVS size and recanalization after IV-tPA. The author suggests that thrombus size on GRE can be easily measured and that the relative size of the thrombus is a useful diagnostic tool. Second, in this study, the MRI slice thickness was 5 mm. If thinner slices are acquired, the approach of summing the cross-sectional areas should be adopted in order to approximate clot volume. Finally, the patient population enrolled in this study was relatively small; thus, more cases are needed. The authors analyzed the correlation between thrombus sizes, as estimated based on GRE SVS and recanalization after treatment and sought to quantify the clot burden. The authors expect that this result may improve decision-making in management of ischemic stroke.

CONCLUSION

The authors found a correlation between thrombus size on GRE and radiologic outcome after IV-tPA. Thrombus size on GRE may be a relative predictor of radiologic outcome. M1 occlusions with small thrombi according to GER SVS were more likely to be recanalized following thrombolysis with IV-tPA. Thrombus size on GRE is a simple diagnostic tool that can be easily measured, for quantitative assessment of clot burden in acute M1 occlusion. It can also be helpful in decision making with regard to use of more aggressive recanalization strategies.

NOTES

This work was supported by the Dong-A University Research Fund.

References

1. Aries MJ, Uyttenboogaart M, Koopman K, Rodiger LA, Vroomen PC, De Keyser J, et al. Hyperdense middle cerebral artery sign and outcome after intravenous thrombolysis for acute ischemic stroke. J Neurol Sci. 2009 10;285(1-2):114-117;

2. Arnold M, Schroth G, Nedeltchev K, Loher T, Remonda L, Stepper F, et al. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke. 2002 7;33(7):1828-1833;

3. Bae YJ, Jung C, Kim JH, Choi BS, Kim E, Han MK, et al. Potential for the use of the Solitaire stent for recanalization of middle cerebral artery occlusion without a susceptibility vessel sign. AJNR Am J Neuroradiol. 2014 1;35(1):149-155;

4. Cho KH, Kim JS, Kwon SU, Cho AH, Kang DW. Significance of susceptibility vessel sign on T2^*-weighted gradient echo imaging for identification of stroke subtypes. Stroke. 2005 11;36(11):2379-2383;

5. Dávalos A, Pereira VM, Chapot R, Bonafé A, Andersson T, Gralla J, et al. Retrospective multicenter study of Solitaire FR for revascularization in the treatment of acute ischemic stroke. Stroke. 2012 10;43(10):2699-2705;

6. Derex L, Nighoghossian N, Hermier M, Adeleine P, Froment JC, Trouillas P. Early detection of cerebral arterial occlusion on magnetic resonance angiography: predictive value of the baseline NIHSS score and impact on neurological outcome. Cerebrovasc Dis. 2002 13(4):225-229;

7. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA. 1999 12;282(21):2003-2011;

8. Gralla J, Brekenfeld C, Mordasini P, Schroth G. Mechanical thrombolysis and stenting in acute ischemic stroke. Stroke. 2012 1;43(1):280-285;

9. Gralla J, Burkhardt M, Schroth G, El-Koussy M, Reinert M, Nedeltchev K, et al. Occlusion length is a crucial determinant of efficiency and complication rate in thrombectomy for acute ischemic stroke. AJNR Am J Neuroradiol. 2008 2;29(2):247-252;

10. Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke. 2003 8;34(8):e109-e137;

11. Kharitonova T, Thorén M, Ahmed N, Wardlaw JM, von Kummer R, Thomassen L, et al. Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical course and prognostic significance. J Neurol Neurosurg Psychiatry. 2009 3;80(3):273-278;

12. Kimura K, Iguchi Y, Shibazaki K, Watanabe M, Iwanaga T, Aoki J. M1 susceptibility vessel sign on T2^* as a strong predictor for no early recanalization after IV-t-PA in acute ischemic stroke. Stroke. 2009 9;40(9):3130-3132;

13. Legrand L, Naggara O, Turc G, Mellerio C, Roca P, Calvet D, et al. Clot burden score on admission T2^*-MRI predicts recanalization in acute stroke. Stroke. 2013 7;44(7):1878-1884;

14. Pai SB, Varma RG, Kulkarni RN. Microsurgical anatomy of the middle cerebral artery. Neurol India. 2005 6;53(2):186-190;

15. Patel MR, Edelman RR, Warach S. Detection of hyperacute primary intraparenchymal hemorrhage by magnetic resonance imaging. Stroke. 1996 12;27(12):2321-2324;

16. Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke. 2009 8;40(8):2761-2768;

17. Sakamoto Y, Kimura K, Sakai K. M1 susceptibility vessel sign and hyperdense middle cerebral artery sign in hyperacute stroke patients. Eur Neurol. 2012 68(2):93-97;

18. Saqqur M, Uchino K, Demchuk AM, Molina CA, Garami Z, Calleja S, et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke. 2007 3;38(3):948-954;

19. Schellinger PD, Chalela JA, Kang DW, Latour LL, Warach S. Diagnostic and prognostic value of early MR Imaging vessel signs in hyperacute stroke patients imaged < 3 hours and treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol. 2005 3;26(3):618-624;

20. Smith WS, Tsao JW, Billings ME, Johnston SC, Hemphill JC 3rd, Bonovich DC, et al. Prognostic significance of angiographically confirmed large vessel intracranial occlusion in patients presenting with acute brain ischemia. Neurocrit Care. 2006 4(1):14-17;

21. Tan IY, Demchuk AM, Hopyan J, Zhang L, Gladstone D, Wong K, et al. CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct. AJNR Am J Neuroradiol. 2009 3;30(3):525-531;

22. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995 12;333(24):1581-1587;

23. Young IR, Khenia S, Thomas DG, Davis CH, Gadian DG, Cox IJ, et al. Clinical magnetic susceptibility mapping of the brain. J Comput Assist Tomogr. 1987 Jan-Feb;11(1):2-6;

Fig. 1

Diffusion weighted imaging (DWI) of a patient shows high signal intensity in the right middle cerebral artery (MCA) territory (A). On magnetic resonance angiography (MRA) showing the area, corresponding to the DWI of (A), a right M1 occlusion is present (B). A gradient echo image susceptibility vessel sign (GRE SVS) is shown on a GRE image (C; white arrow). The cross-sectional area of the thrombus was calculated using the Picture Archiving and Communication System (PACS; Maroview version 5.4, MAROTECH Inc., Seoul, Korea). In this case, the calculated cross-sectional area of the thrombus was 25.07 mm² (D).

Fig. 2

Receiver operator characteristic (ROC) curve analysis of thrombus size and recanalization: The area under the curve was 0.687, the sensitivity was 73.3%, the specificity was 60%, and the cut-off value was 47.28 mm².